Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (Tandem scFv)
TypeName: Business Offer
Category:
Country: United States
Summary: Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-doxorubicin antibody variable domains fused with a scFv from an anti-EGFR antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can be used in pretargeting system and deliver toxin to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. https://www.creative-biolabs.com/bsab/symbolsearch-doxorubicin%2520%2526%2520egfr.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
